Bayshore Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Bayshore Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,852	Closed	-$228K	–	42
2025 Q2	$228K	Hold	4,852	–	–	0.1%	40
2025 Q1	$214K	Buy	+4,852	New	+$223K	0.11%	36
2024 Q2	–	Sell	-4,852	Closed	-$239K	–	42
2024 Q1	$239K	Buy	+4,852	New	+$224K	0.12%	37

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Bayshore Asset Management's SWTX Position: Q3 2025 in Review

Bayshore Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4,852 shares — an estimated $228K sold.

Bayshore Asset Management first reported a position in SWTX in Q1 2024 and held it in 3 quarters. The position peaked at $239K in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Bayshore Asset Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Bayshore Asset Management sold 4,852 SpringWorks Therapeutics shares in Q3 2025, an estimated $228K.
Bayshore Asset Management first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 3 quarters.
Bayshore Asset Management's SpringWorks Therapeutics position peaked at $239K in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Bayshore Asset Management's 13F filing for Q3 2025, filed 31 Oct 2025.